BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2645716)

  • 1. Increased frequency of posttransplant lymphomas in patients treated with cyclosporine, azathioprine, and prednisone.
    Wilkinson AH; Smith JL; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ
    Transplantation; 1989 Feb; 47(2):293-6. PubMed ID: 2645716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone.
    Smith JL; Wilkinson AH; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3199-200. PubMed ID: 2650451
    [No Abstract]   [Full Text] [Related]  

  • 3. A prospective randomized trial of pretransfusion/azathioprine/prednisone versus cyclosporine/prednisone immunosuppression in cardiac transplant recipients: preliminary results.
    Barnhart GR; Hastillo A; Goldman MH; Szentpetery S; Wolfgang TC; Mohanakumar T; Katz MR; Rider S; Hanrahan J; Lower RR
    Circulation; 1985 Sep; 72(3 Pt 2):II227-30. PubMed ID: 3896555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine.
    Canafax DM; Torres A; Fryd DS; Heil JE; Strand MH; Ascher NL; Payne WD; Sutherland DE; Simmons RL; Najarian JS
    Transplantation; 1986 Feb; 41(2):177-81. PubMed ID: 3511581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP; McHugh L; Canafax DM; Ascher N; Sutherland DE; Payne W; Simmons RL; Najarian JS; Fryd DS
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM; Canafax DM; Gillingham KJ; Humar A; Pandian K; Kerr SR; Najarian JS; Matas AJ
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An increased incidence of late acute rejection episodes in cadaver renal allograft recipients given azathioprine, cyclosporine, and prednisone.
    Wrenshall LE; Matas AJ; Canafax DM; Min DI; Sibley RJ; Dunn DL; Payne WD; Sutherland DE; Najarian JS
    Transplantation; 1990 Aug; 50(2):233-7. PubMed ID: 2382291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-lymphocyte subsets in renal allograft recipients treated with cyclosporine and azathioprine.
    Sumpio BE; Dwyer JM; Flye MW
    Ann Surg; 1987 Jan; 205(1):49-53. PubMed ID: 3541801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of immunosuppression therapy following heart transplantation: pretransfusion/azathioprine/ATG/prednisone versus cyclosporine/prednisone.
    Barnhart GR; Goldman MH; Hastillo A; Szentpetery S; Wolfgang T; Thompson J; Mohanakumar T; Katz MR; Rider S; Hanrahan J
    J Heart Transplant; 1985; 4(4):381-4. PubMed ID: 3916511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
    Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
    Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppression after heart transplantation: prednisone and cyclosporine with and without azathioprine.
    Casale AS; Reitz BA; Greene PS; Augustine S; Baumgartner WA
    J Thorac Cardiovasc Surg; 1989 Nov; 98(5 Pt 2):951-5. PubMed ID: 2811426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of triple-drug-based immunosuppression in nonneonatal pediatric heart transplant recipients.
    Gajarski RJ; Smith EO; Denfield SW; Rosenblatt HM; Kearney D; Frazier OH; Radovancevic B; Price JK; Kertesz NJ; Towbin JA
    Transplantation; 1998 Jun; 65(11):1470-6. PubMed ID: 9645805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excellent outcome with a calcium channel blocker-supplemented immunosuppressive regimen in cadaveric renal transplantation. A potential strategy to avoid antibody induction protocols.
    Suthanthiran M; Haschemeyer RH; Riggio RR; Adubor C; Friedman GS; Cheigh JS; Wang JC; Fotino M; Stubenbord WT; Saal SD
    Transplantation; 1993 May; 55(5):1008-13. PubMed ID: 8497873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of 2-drug and 3-drug immunosuppression for cadaveric renal transplantation.
    Martin DC; Tertzakian G; Ruzics E
    J Urol; 1990 May; 143(5):900-1. PubMed ID: 2329602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and severity of acute cardiac allograft rejection with two different low-dose cyclosporine maintenance protocols.
    Laufer G; Laczkovics A; Wollenek G; Schreiner W; Kober I; Wolner E
    Ann Thorac Surg; 1988 Oct; 46(4):382-8. PubMed ID: 3052335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of kidney transplant survival between patients treated with cyclosporine and those treated with azathioprine and antithymocyte globulin.
    Cho SI; Bradley JW; Monaco AP; Tilney NL
    Am J Surg; 1984 Apr; 147(4):518-23. PubMed ID: 6370008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation.
    Barr ML; Sanchez JA; Seche LA; Schulman LL; Smith CR; Rose EA
    Circulation; 1990 Nov; 82(5 Suppl):IV291-4. PubMed ID: 2121387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin A for immunosuppression: observations in rat heart, pancreas, and islet allograft models and in human renal and pancreas transplantation.
    Rynasiewicz JJ; Sutherland DE; Ferguson RM; Squifflet JP; Morrow CE; Goetz FC; Najarian JS
    Diabetes; 1982 Aug; 31 Suppl 4():92-108. PubMed ID: 6819969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.